Surgivance, Inc.
Publicly observedPortland, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Portland | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Surgivance, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | JH4EDZ5CQZD5 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant18 Jun 2025Publicly observed
NIH SBIR/STTR award: Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demand
USD 1,271,776.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant18 Jun 2025Publicly observed
NIH SBIR/STTR award: Rapid 3D POC digital cancer pathology by unique confocal microscopy instrumentation and downstream AI: a simple, efficient, robust direct-to-digital approach to meet market demand
USD 978,154.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.